Key result
CSP-AIso-NCs treatment improved cardiac function, reduced oxidative stress and inflammatory cytokines, and ameliorated isoproterenol-induced myocardial infarction in rats.
Why the study?
Myocardial infarction is a common ischemic heart disease worldwide, and the study aimed to synthesize CSP-AIso-NCs and evaluate their effects against isoproterenol-induced MI in rats.
Do CSP-AIso-NCs improve cardiac function and reduce injury in rats with isoproterenol-induced myocardial infarction?
Do CSP-AIso-NCs improve cardiac function and reduce injury in rats with isoproterenol-induced myocardial infarction?
CSP-AIso-NCs demonstrate cardioprotective effects against isoproterenol-induced myocardial infarction in a rat model by improving cardiac function, reducing oxidative stress, and decreasing inflammation.
Hypothesis-generating for nanocomposite cardioprotection in rat MI; leaves open human translation.
Myocardial infarction (MI) is a common type of ischemic heart disease that affects millions of people worldwide. In recent times, nanotechnology has become a very promising field with immense applications. The current exploration was conducted to synthesize the chitosan‐sodium alginate‐polyethylene glycol‐Ally isothiocyanate nanocomposites (CSP‐AIso‐NCs) and evaluate their beneficial roles against the isoproterenol (ISO)‐induced MI in rats. The CSP‐AIso‐NCs were prepared and characterized by several characterization techniques. The MI was initiated in the rats by the administration of 85 mg/kg of ISO for 2 days and treated with 10 and 20 mg/kg of CSP‐AIso‐NCs for 1 month. The changes in heart weight and bodyweight were measured. The cardiac function markers were assessed with echocardiography. The lipid profiles, Na+, K+, and Ca2+ ions, cardiac biomarkers, antioxidant parameters, and inflammatory cytokines were assessed using corresponding assay kits. The histopathological study was done on the heart tissues. The UV spectral analysis revealed the maximum peak at 208 nm, which confirms the formation of CSP‐AIso‐NCs. The FT‐IR analysis revealed the occurrence of different functional groups, and the crystallinity of the CSP‐AIso‐NCs was proved by the XRD analysis. DLS analysis indicated the size of the CSP‐AIso‐NCs at 146.50 nm. The CSP‐AIso‐NCs treatment increased the bodyweight and decreased the HW/BW ratio in the MI rats. The status of lipids was reduced, and HDL was elevated in the CSP‐AIso‐NCs administered to MI rats. CSP‐AIso‐NCs decreased the LVEDs, LVEDd, and NT‐proBNP and increased the LVEF level. The oxidative stress markers were decreased, and the antioxidants were increased by the CSP‐AIso‐NCs treatment in the MI rats. The Na+ and Ca+ ions were reduced, and the K+ ions were increased by the CSP‐AIso‐NCs. The interleukin‐1β and tumor necrosis factor‐α were also depleted, and Nrf‐2 was improved in the CSP‐AIso‐NCs administered to MI rats. The histological study revealed the ameliorative effects of CSP‐AIso‐NCs. Overall, our outcomes revealed that the CSP‐AIso‐NCs are effective against the ISO‐induced MI rats. Hence, it could be a hopeful therapeutic nanomedicine for MI treatment.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2023) studied Isoproterenol-induced myocardial infarction. Chitosan-sodium alginate-polyethylene glycol-Ally isothiocyanate nanocomposites (CSP-AIso-NCs) vs. Untreated MI rats was evaluated. CSP-AIso-NCs treatment improved cardiac function, reduced oxidative stress and inflammatory cytokines, and ameliorated isoproterenol-induced myocardial infarction in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: